WRF
ABMD

Waddell & Reed Financial’s Abiomed Inc ABMD Stock Holding History

Waddell & Reed Financial’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$152M Sell
476,711
-86,738
-15% -$27.8M 0.31% 81
2020
Q4 		$183M Buy
563,449
+41,091
+8% +$11.4M 0.39% 66
2020
Q3 		$145M Buy
522,358
+38,164
+8% +$11M 0.35% 68
2020
Q2 		$117M Sell
484,194
-2,467
-0.5% -$495K 0.3% 89
2020
Q1 		$70.6M Buy
486,661
+43,962
+10% +$7.3M 0.23% 120
2019
Q4 		$75.5M Sell
442,699
-16,997
-4% -$3.15M 0.19% 151
2019
Q3 		$81.8M Sell
459,696
-154,677
-25% -$33.4M 0.21% 134
2019
Q2 		$160M Buy
614,373
+70,605
+13% +$18.7M 0.4% 66
2019
Q1 		$155M Buy
543,768
+13,348
+3% +$4.44M 0.38% 67
2018
Q4 		$172M Buy
530,420
+24,269
+5% +$8.43M 0.49% 49
2018
Q3 		$228M Buy
506,151
+51,007
+11% +$20.1M 0.5% 44
2018
Q2 		$186M Sell
455,144
-30,613
-6% -$11.1M 0.43% 58
2018
Q1 		$141M Buy
485,757
+180,423
+59% +$45.7M 0.32% 82
2017
Q4 		$57.2M Buy
305,334
+131,120
+75% +$24.5M 0.13% 189
2017
Q3 		$29.4M Buy
+174,214
New +$26.3M 0.07% 287

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Waddell & Reed Financial's ABMD Position: Q1 2021 in Review

Waddell & Reed Financial reduced its Abiomed Inc (ABMD) stake by 15% in Q1 2021, selling an estimated $27.8M and leaving 476,711 shares worth $152M. The position accounts for 0.31% of the portfolio, ranked #81.

Waddell & Reed Financial first reported a position in ABMD in Q3 2017 and has held it in 15 quarters since. The position peaked at $228M in Q3 2018. 488 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

  • Waddell & Reed Financial held 476,711 shares of Abiomed Inc worth $152M as of Q1 2021.
  • Waddell & Reed Financial sold 86,738 Abiomed Inc shares in Q1 2021, an estimated $27.8M.
  • Abiomed Inc made up 0.31% of Waddell & Reed Financial's portfolio in Q1 2021, its #81 holding.
  • Waddell & Reed Financial first reported a position in Abiomed Inc in Q3 2017 and has held it in 15 quarters since.
  • Waddell & Reed Financial's Abiomed Inc position peaked at $228M in Q3 2018.
  • 488 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.